Real-time enrollment status for this irritable bowel syndrome clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06153420 |
| Recruiting Status | Terminated |
| Condition | Irritable Bowel Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 450 participants |
| Active Locations | 53 sites in the US |
| Sponsor | CinPhloro Pharma, LLC |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of March 2, 2026: Clinical trial NCT06153420 is currently terminated participants. This clinical trial study for irritable bowel syndrome is not currently accepting new participants at 53 locations across the United States. The study is sponsored by CinPhloro Pharma, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06153420 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 53 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06153420 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.